National Scrapie Eradication Program
 
April 2016 Monthly Report
 
Fiscal Year 2016
 
U.S. Department of Agriculture
 
Animal and Plant Health Inspection Service
 
Veterinary Services
 
Surveillance, Preparedness and Response Services
 
Sheep and Goat Health Program 
 
May 15, 2016 
 
snip... 
 
Surveillance
 
Regulatory Scrapie Slaughter Surveillance (RSSS)
 
RSSS started April 1, 2003. It is a targeted slaughter surveillance program 
which is designed to identify infected flocks. Samples have been collected from 
503,973 animals since April 1, 2003. There have been 479 NVSL confirmed positive 
animals* (471 classical cases and 8 Nor98-like cases) since the beginning of 
RSSS. As of April 30, 2016, 21,371 samples have been collected in FY 2016, 
16,854 from sheep and 4,517 from goats. 
 
As of April 30, 2016, one black-faced sheep* tested positive for scrapie in 
FY 2016. The weighted percentage of samples that have tested positive for each 
face color** from FY 2003 through FY 2016 is depicted in Chart 3a. In November 
2013, administrative units within APHIS Veterinary Services reorganized from 2 
Regions to 6 Districts (Figure 6). The distribution of sheep and goat 
populations by District is depicted in Chart 4a. The number of animals collected 
for FY 2016 by District where collected is shown in Chart 4b. A monthly 
comparison of RSSS collections by fiscal year is displayed in Chart 5. Chart 6is 
a retrospective 6-month rolling average of the percent positive, black-faced 
sheep sampled at RSSS collection sites.
 
* RSSS positives are reported based on collection date and may have been 
confirmed after April 30, 2016.
 
** White, black and mottled face color sheep are weighted based on 
population. White faced sheep have the highest weight, so when the uncommon 
white face positive sheep is found it will cause this statistic to increase. 
 
snip... 
 
Positive Cases and Infected/Source Flocks
 
Positive Scrapie Cases*
 
Thirteen positive cases have been reported in FY 2016. Eight of the cases 
were from a source flock that was designated in October because of an RSSS 
positive animal reported in September 2015. Location of the cases is shown in 
Table 1 and Figure 1, and distribution by face-color (sheep) and type (goats) is 
shown in Table 2.
 
The 2 positive goat cases found in FY 2015 increased the number of 
confirmed cases in goats since FY 2002 to 41 (Figure 2). No goats have tested 
positive in FY 2016.
 
Infected and Source Flocks
 
As of April 30, 2016, there were four flocks with an open infected or 
source status (Figure 3). Two infected and three source flocks have been 
designated in FY 2016 (Figure 4); two flocks have completed clean-up plans and 
have been released (Figure 5). New infected and source statuses from FY 1997 to 
FY 2016 are depicted in Chart 2.
 
* Samples collected between October 1, 2015 and April 30, 2016 and 
confirmed by May 15, 2016.
 
 
IL-13 Transmission of prions to non human-primates: Implications for human 
populations 
 
Jean-Philippe Deslys, Emmanuel E. Comoy 
 
CEW, Institute of Emerging Diseases and Innovative Therapies (iMETI), 
Division of Prions and Related Diseases (SEPIA), Fontenay-aux-Roses, France 
 
Prion diseases are the unique neurodegenerative proteinopathies reputed to 
be transmissible under field conditions since decades. The transmission of 
Bovine Spongiform Encephalopathy (BSE) to humans evidenced that an animal prion 
disease might be zoonotic under appropriate conditions. Contrarily, in the 
absence of obvious (epidemiological or experimental) elements supporting a 
transmission or genetic predispositions, prion diseases, like the other 
proteinopathies, are reputed to occur spontaneously (atypical animal prion 
strains, sporadic CJD summing 80 % of human prion cases). 
 
Non-human primate models provided the first evidences supporting the 
transmissibility of human prion strains and the zoonotic potential of BSE. Among 
them, cynomolgus macaques brought major information for BSE risk assessment for 
human health1, according to their phylogenetic proximity to humans and extended 
lifetime. We used this model to assess the risk of primary (oral) and secondary 
(transfusional) risk of BSE, and also the zoonotic potential of other animal 
prion diseases from bovine, ovine and cervid origins even after very long silent 
incubation periods. 
 
We recently observed the direct transmission of a natural classical scrapie 
isolate to macaque after a 10-year silent incubation period, with features 
similar to some reported for human cases of sporadic CJD, albeit requiring 
fourfold' . longer incubation than BSE2. Scrapie, as recently evoked in 
humanized mice3, is the third potentially zoonotic prion disease (with BSE and 
L-type BSE4), thus questioning the origin of human sporadic cases. We also 
observed hidden prions transmitted by blood transfusion in primate which escape 
to the classical diagnostic methods and extend the field of healthy carriers. We 
will present an updated panorama of our different long-term transmission studies 
and discuss the implications on risk assessment of animal prion diseases for 
human health and of the status of healthy carrier5. 
 
1. Chen, C. C. & Wang, Y. H. Estimation of the Exposure of the UK 
Population to the Bovine Spongiform Encephalopathy Agent through Dietary Intake 
During the Period 1980 to 1996. PLoS One 9, e94020 (2014). 
 
2. Comoy, E. E. et al. Transmission of scrapie prions to primate after an 
extended silent incubation period. Sci Rep 5, 11573 (2015). 
 
3. Cassard, H. et al. Evidence for zoonotic potential of ovine scrapie 
prions. Nat Commun 5, 5821-5830 (2014). 
 
4. Comoy, E. E. et al. Atypical BSE (BASE) transmitted from asymptomatic 
aging cattle to a primate. PLoS One 3, e3017 (2008). 
 
5. Gill O. N. et al. Prevalent abnormal prion protein in human appendixes 
after bovine spongiform encephalopathy epizootic: large scale survey. BMJ. 347, 
f5675 (2013). 
 
Curriculum Vitae 
 
Dr. Deslys co-authored more than one hundred publications in international 
scientific journals on main aspects of applied prion research (diagnostic, 
decontamination techniques, risk assessment, and therapeutic approaches in 
different experimental models) and on underlying pathological mechanisms. He 
studied the genetic of the first cases of iatrogenic CJD in France. His work has 
led to several patents including the BSE (Bovine Spongiform Encephalopathy) 
diagnostic test most widely used worldwide. He also wrote a book on mad cow 
disease which can be downloaded here for free (
http://www.neuroprion.org/pdf_docs/documentation/madcow_deslys.pdf). 
His research group is Associate Laboratory to National Reference Laboratory for 
CJD in France and has high security level microbiological installations 
(NeuroPrion research platform) with different experimental models (mouse, 
hamster, macaque). The primate model of BSE developed by his group with 
cynomolgus macaques turned out to mimick remarkably well the human situation and 
allows to assess the primary (oral) and secondary (transfusional) risks linked 
to animal and human prions even after very long silent incubation periods. For 
several years, his interest has extended to the connections between PrP and 
Alzheimer and the prion mechanisms underlying neurodegenerative diseases. He is 
coordinating the NeuroPrion international association (initially european 
network of excellence now open to all prion researchers). 
 
 
- 59- 
 
P-088 Transmission of experimental CH1641-like scrapie to bovine PrP 
overexpression mice 
 
Kohtaro Miyazawa1, Kentaro Masujin1, Hiroyuki Okada1, Yuichi Matsuura1, 
Takashi Yokoyama2 
 
1Influenza and Prion Disease Research Center, National Institute of Animal 
Health, NARO, Japan; 2Department of Planning and General Administration, 
National Institute of Animal Health, NARO 
 
Introduction: Scrapie is a prion disease in sheep and goats. CH1641-lke 
scrapie is characterized by a lower molecular mass of the unglycosylated form of 
abnormal prion protein (PrpSc) compared to that of classical scrapie. It is 
worthy of attention because of the biochemical similarities of the Prpsc from 
CH1641-like and BSE affected sheep. We have reported that experimental 
CH1641-like scrapie is transmissible to bovine PrP overexpression (TgBoPrP) mice 
(Yokoyama et al. 2010). We report here the further details of this transmission 
study and compare the biological and biochemical properties to those of 
classical scrapie affected TgBoPrP mice. 
 
Methods: The details of sheep brain homogenates used in this study are 
described in our previous report (Yokoyama et al. 2010). TgBoPrP mice were 
intracerebrally inoculated with a 10% brain homogenate of each scrapie strain. 
The brains of mice were subjected to histopathological and biochemical analyses. 
 
Results: Prpsc banding pattern of CH1641-like scrapie affected TgBoPrP mice 
was similar to that of classical scrapie affected mice. Mean survival period of 
CH1641-like scrapie affected TgBoPrP mice was 170 days at the 3rd passage and it 
was significantly shorter than that of classical scrapie affected mice (439 
days). Lesion profiles and Prpsc distributions in the brains also differed 
between CH1641-like and classical scrapie affected mice. 
 
Conclusion: We succeeded in stable transmission of CH1641-like scrapie to 
TgBoPrP mice. Our transmission study demonstrates that CH 1641-like scrapie is 
likely to be more virulent than classical scrapie in cattle. 
 
 WS-02 
 
Scrapie in swine: A diagnostic challenge 
 
Justin J Greenlee1, Robert A Kunkle1, Jodi D Smith1, Heather W. Greenlee2 
 
1National Animal Disease Center, US Dept. of Agriculture, Agricultural 
Research Service, United States; 2Iowa State University College of Veterinary 
Medicine 
 
A naturally occurring prion disease has not been recognized in swine, but 
the agent of bovine spongiform encephalopathy does transmit to swine by 
experimental routes. Swine are thought to have a robust species barrier when 
exposed to the naturally occurring prion diseases of other species, but the 
susceptibility of swine to the agent of sheep scrapie has not been thoroughly 
tested. 
 
Since swine can be fed rations containing ruminant derived components in 
the United States and many other countries, we conducted this experiment to test 
the susceptibility of swine to U.S. scrapie isolates by intracranial and oral 
inoculation. Scrapie inoculum was a pooled 10% (w/v) homogenate derived from the 
brains of clinically ill sheep from the 4th passage of a serial passage study of 
the U.S scrapie agent (No. 13-7) through susceptible sheep that were homozygous 
ARQ at prion protein residues 136, 154, and 171, respectively. Pigs were 
inoculated intracranially (n=19) with a single 0.75 ml dose or orally (n=24) 
with 15 ml repeated on 4 consecutive days. Necropsies were done on a subset of 
animals at approximately six months post inoculation (PI), at the time the pigs 
were expected to reach market weight. Remaining pigs were maintained and 
monitored for clinical signs of TSE until study termination at 80 months PI or 
when removed due to intercurrent disease (primarily lameness). Brain samples 
were examined by immunohistochemistry (IHC), western blot (WB), and 
enzyme-linked immunosorbent assay (ELISA). Brain tissue from a subset of pigs in 
each inoculation group was used for bioassay in mice expressing porcine PRNP. 
 
At six-months PI, no evidence of scrapie infection was noted by any 
diagnostic method. However, at 51 months of incubation or greater, 5 animals 
were positive by one or more methods: IHC (n=4), WB (n=3), or ELISA (n=5). 
Interestingly, positive bioassay results were obtained from all inoculated 
groups (oral and intracranial; market weight and end of study). 
 
Swine inoculated with the agent of scrapie by the intracranial and oral 
routes do not accumulate abnormal prion protein (PrPSc) to a level detectable by 
IHC or WB by the time they reach typical market age and weight. However, strong 
support for the fact that swine are potential hosts for the agent of scrapie 
comes from positive bioassay from both intracranially and orally inoculated pigs 
and multiple diagnostic methods demonstrating abnormal prion protein in 
intracranially inoculated pigs with long incubation times. 
 
Curriculum Vitae 
 
Dr. Greenlee is Research Veterinary Medical Officer in the Virus and Prion 
Research Unit at the National Animal Disease Center, US Department of 
Agriculture, Agricultural Research Service. He applies his specialty in 
veterinary anatomic pathology to focused research on the intra- and interspecies 
transmission of prion diseases in livestock and the development of antemortem 
diagnostic assays for prion diseases. In addition, knockout and transgenic mouse 
models are used to complement ongoing experiments in livestock species. Dr. 
Greenlee has publications in a number of topic areas including prion agent 
decontamination, effects of PRNP genotype on susceptibility to the agent of 
sheep scrapie, characterization of US scrapie strains, transmission of chronic 
wasting disease to cervids and cattle, features of H-BSE associated with the 
E211 K polymorphism, and the development of retinal assessment for antemortem 
screening for prion diseases in sheep and cattle. Dr. Greenlee obtained his DVM 
degree and completed the PhD/residency program in Veterinary Pathology at Iowa 
State University. He is a Diplomate of the American College of Veterinary 
Pathologists. 
 
 
 >>>A naturally occurring prion disease has not been recognized in 
swine, but the agent of bovine spongiform encephalopathy does transmit to swine 
by experimental routes. <<< 
 
for anyone interested, please see old studies here ;
 
IN CONFIDENCE 
 
EXPERIMENTAL PORCINE SPONGIFORM ENCEPHALOPATHY 1. CMO should be aware that 
a pig inoculated experimentally (ic, iv, and ip) with BSE brain suspension has 
after 15 months developed an illness, now confirmed as a spongiform 
encephalopathy. This is the first ever description of such a disease in a pig, 
although it seems there ar no previous attempts at experimental inoculation with 
animal material. The Southwood group had thought igs would not be susceptible. 
Most pigs are slaughtered when a few weeks old but there have been no reports of 
relevant neurological illness in breeding sows or other elderly pigs. 
 
...see full text ; 
 
 
IN CONFIDENCE 
 
So it is plausible pigs could be preclinically affected with BSE but since 
so few are allowed to reach adulthood this has not been recognised through 
clinical disease. ... 
 
 
snip... 
 
CONFIDENTIAL EXPERIMENTAL PORCINE SPONGIFORM ENCEPHALOPATHY 
 
PLEASE NOTE, these old BSE Inquiry links take a while to open with the 
wayback machine, so be patient. ...tss 
 
Title: Experimental Intracerebral and Oral Inoculation of Scrapie to Swine: 
Preliminary Report In the United States, feeding of ruminant by-products to 
ruminants is prohibited, but feeding of ruminant materials to swine and poultry 
still occurs. The potential for swine to have access to scrapie-contaminated 
feedstuffs exists, but the potential for swine to serve as a host for 
replication/accumulation of the agent of scrapie is unknown. The purpose of this 
study was to perform oral and intracerebral inoculation of the U.S. scrapie 
agent to determine the potential of swine as a host for the scrapie agent and 
their clinical susceptibility. 
 
snip... 
 
IN CONFIDENCE EXPERIMENTAL PORCINE SPONGIFORM ENCEPHALOPATHY 1. CMO should 
be aware that a pig inoculated experimentally (ic, iv, and ip) with BSE brain 
suspension has after 15 months developed an illness, now confirmed as a 
spongiform encephalopathy. This is the first ever description of such a disease 
in a pig, although it seems there ar no previous attempts at experimental 
inoculation with animal material. The Southwood group had thought igs would not 
be susceptible. Most pigs are slaughtered when a few weeks old but there have 
been no reports of relevant neurological illness in breeding sows or other 
elderly pigs. ...see full text ; 
 
 
we cannot rule out the possibility that unrecognised subclinical spongiform 
encephalopathy could be present in British pigs though there is no evidence for 
this: only with parenteral/implantable pharmaceuticals/devices is the 
theoretical risk to humans of sufficient concern to consider any action. 
 
 
May I, at the outset, reiterate that we should avoid dissemination of 
papers relating to this experimental finding to prevent premature release of the 
information. ... 
 
 
3. It is particularly important that this information is not passed outside 
the Department, until Ministers have decided how they wish it to be handled. ... 
 
 
But it would be easier for us if pharmaceuticals/devices are not directly 
mentioned at all. ...
 
 
Our records show that while some use is made of porcine materials in 
medicinal products, the only products which would appear to be in a 
hypothetically ''higher risk'' area are the adrenocorticotrophic hormone for 
which the source material comes from outside the United Kingdom, namely America 
China Sweden France and Germany. The products are manufactured by Ferring and 
Armour. A further product, ''Zenoderm Corium implant'' manufactured by Ethicon, 
makes use of porcine skin - which is not considered to be a ''high risk'' 
tissue, but one of its uses is described in the data sheet as ''in dural 
replacement''. This product is sourced from the United Kingdom..... 
 
 
snip... 
 
It was not until . . . August 1990, that the result from the pig persuaded 
both SEAC and us to change our view and to take out of pig rations any residual 
infectivity that might have arisen from the SBOs. 
 
 
4.303 The minutes of the meeting record that: It was very difficult to draw 
conclusions from one experimental result for what may happen in the field. 
However it would be prudent to exclude specified bovine offals from the pig 
diet. Although any relationship between BSE and the finding of a spongiform 
encephalopathy in cats had yet to be demonstrated, the fact that this had 
occurred suggested that a cautious view should be taken of those species which 
might be susceptible. The 'specified offals' of bovines should therefore be 
excluded from the feed of all species. 17
 
 
7 OF 10 LITTLE PIGGIES WENT ON TO DEVELOP BSE; 
 
1: J Comp Pathol. 2000 Feb-Apr; 122(2-3): 131-43. Related Articles, Links 
Click here to read 
 
The neuropathology of experimental bovine spongiform encephalopathy in the 
pig. 
 
Ryder SJ, Hawkins SA, Dawson M, Wells GA. Veterinary Laboratories Agency 
Weybridge, Woodham Lane, New Haw, Addlestone, Surrey, KT15 3NB, UK. 
 
In an experimental study of the transmissibility of BSE to the pig, seven 
of 10 pigs, infected at 1-2 weeks of age by multiple-route parenteral 
inoculation with a homogenate of bovine brain from natural BSE cases developed 
lesions typical of spongiform encephalopathy. The lesions consisted principally 
of severe neuropil vacuolation affecting most areas of the brain, but mainly the 
forebrain. In addition, some vacuolar change was identified in the rostral 
colliculi and hypothalamic areas of normal control pigs. PrP accumulations were 
detected immunocytochemically in the brains of BSE-infected animals. PrP 
accumulation was sparse in many areas and its density was not obviously related 
to the degree of vacuolation. The patterns of PrP immunolabelling in control 
pigs differed strikingly from those in the infected animals. PMID: 10684682 
[PubMed - indexed for MEDLINE] 
 
 
Transgenic mice expressing porcine prion protein resistant to classical 
scrapie but susceptible to sheep bovine spongiform encephalopathy and atypical 
scrapie. 
 
Emerg Infect Dis. 2009 Aug; [Epub ahead of print] 
 
 
snip...
 
Friday, August 21, 2015 
 
Porcine prion protein amyloid or mad pig disease PSE Porcine Spongiform 
Encephalopathy ? 
 
 
 
In the US, scrapie is reported primarily in sheep homozygous for 136A/171Q 
(AAQQ) and the disease phenotype is similar to that seen with experimental 
strain CH1641. 
 
 
 
Monday, April 11, 2016 
 
*** DECLARATION OF EXTRAORDINARY EMERGENCY DUE TO A FOREIGN ANIMAL DISEASE 
TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY TSE PRION CHRONIC WASTING DISEASE CWD IN 
THE UNITED STATES AND NORTH AMERICA ? 
 
Diagnosing TSE Prion disease in the USA, and the ‘’REDACTED’’ factor on 
sound atypical Scrapie TSE Prion testing by the USDA APHIS et al, and 10 years 
of FOIA request
 
 
Monday, April 11, 2016 
 
 ***DECLARATION OF EXTRAORDINARY EMERGENCY DUE TO A FOREIGN ANIMAL DISEASE 
TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY TSE PRION CHRONIC WASTING DISEASE CWD IN 
THE UNITED STATES AND NORTH AMERICA ? *** 
 
 MAD SHEEP OF MAD RIVER VALLEY AND THE USDA ‘FALSE FLAG’ WAR ON THAT 
FAMILY, AND WHY TODAY A DECLARATION OF EXTRAORDINARY EMERGENCY DUE TO A FOREIGN 
ANIMAL DISEASE TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY TSE PRION CHRONIC WASTING 
DISEASE CWD IN THE UNITED STATES AND NORTH AMERICA MUST BE CALLED FOR !!! 
 
 
 Friday, February 20, 2015 
 
 ***APHIS Freedom of Information Act (FOIA) Appeal Mouse Bio-Assays 
2007-00030-A Sheep Imported From Belgium and the Presence of TSE Prion Disease 
Kevin Shea to Singeltary 2015 
 
 
 Friday, August 21, 2015 
 
Porcine prion protein amyloid or mad pig disease PSE Porcine Spongiform 
Encephalopathy ? 
 
 
 
CJD/BSE (aka madcow) Human/Animal TSE’s--U.S.--Submission To Scientific 
Advisors and Consultants Staff January 2001 Meeting (short version)
 
Freas, William
 
From: Terry S. Singeltary Sr. [flounder@wt.net]
 
Sent: Monday, January 08,2001 3:03 PM
 
TO: freas@CBS5055530.CBER.FDA.GOV
 
Subject: CJD/BSE (aka madcow) Human/Animal TSE’s--U.S.--Submission To 
Scientific Advisors and Consultants Staff January 2001 Meeting (short 
version)
 
CJD/BSE (aka madcow) Human/Animal TSE’s--U.S.--Submission To Scientific 
Advisors and Consultants Staff January 2001 Meeting (short version)
 
Greetings again Dr. Freas and Committee Members,
 
I wish to submit the following information to the Scientific Advisors and 
Consultants Staff 2001 Advisory Committee (short version).
 
I understand the reason of having to shorten my submission, but only hope 
that you add it to a copy of the long version, for members to take and read at 
their pleasure, (if cost is problem, bill me, address below). So when they 
realize some time in the near future of the 'real' risks i speak of from 
human/animal TSEs and blood/surgical products. I cannot explain the 'real' risk 
of this in 5 or 10 minutes at some meeting, or on 2 or 3 pages, but will attempt 
here:
 
remember AIDS/HIV, 'no problem to heterosexuals in the U.S.? no need to go 
into that, you know of this blunder:
 
DO NOT make these same stupid mistakes again with human/animal TSE's aka 
MADCOW DISEASE. I lost my Mom to hvCJD, and my neighbor lost his Mother to sCJD 
as well (both cases confirmed). I have seen many deaths, from many diseases. I 
have never seen anything as CJD, I still see my Mom laying helpless, jerking 
tremendously, and screaming "God, what's wrong with me, why can't I stop this". 
I still see this, and will never forget. Approximately 10 weeks from 1st of 
symptoms to death. This is what drives me. I have learned more in 3 years about 
not only human/animal TSE's but the cattle/rendering/feeding industry/government 
than i ever wished to.
 
I think you are all aware of CJD vs vCJD, but i don't think you all know 
the facts of human/animal TSE's as a whole, they are all very very similar, and 
are all tied to the same thing, GREED and MAN.
 
I am beginning to think that the endless attempt to track down and ban, 
potential victims from known BSE Countries from giving blood will be futile. You 
would have to ban everyone on the Globe eventually? AS well, I think we MUST ACT 
SWIFTLY to find blood test for TSE's, whether it be blood test, urine test, 
.eyelid test, anything at whatever cost, we need a test FAST. 
 
DO NOT let the incubation time period of these TSEs fool you.
 
To think of Scrapie as the prime agent to compare CJD, but yet overlook the 
Louping-ill vaccine event in 1930's of which 1000's of sheep where infected by 
scrapie from a vaccine made of scrapie infected sheep brains, would be foolish. 
I acquired this full text version of the event which was recorded in the Annual 
Congress of 1946 National Vet. Med. Ass. of Great Britain and Ireland. from the 
BVA and the URL is posted in my (long version).
 
U.S.A. should make all human/animal TSE's notifiable at all ages, with 
requirements for a thorough surveillance and post-mortem examinations free of 
charge, if you are serious about eradicating this horrible disease in man and 
animal.
 
There is histopathology reports describing o florid plaques" in CJD victims 
in the USA and some of these victims are getting younger. I have copies of such 
autopsies, there has to be more. PLUS, sub-clinical human TSE's will most 
definitely be a problem.
 
THEN think of vaccineCJD in children and the bovine tissues used in the 
manufacturing process, think of the FACT that this agent surviving 6OO*C. PNAS 
-- Brown et al. 97 (7): 3418 scrapie agent live at 600*C
 
Then think of the CONFIDENTIAL documents of what was known of human/animal 
TSE and vaccines in the mid to late 80s, it was all about depletion of stock, to 
hell with the kids, BUT yet they knew. To think of the recall and worry of TSE's 
from the polio vaccine, (one taken orally i think?), but yet neglect to act on 
the other potential TSE vaccines (inoculations, the most effective mode to 
transmit TSEs) of which thousands of doses were kept and used, to deplete 
stockpile, again would be foolish.
 
--Oral polio; up to 1988, foetal calf serum was used from UK and New 
Zealand (pooled); since 1988 foetal calf serum only from New Zealand. Large 
stocks are held.
 
--Rubella; bulk was made before 1979 from foetal calf serum from UK and New 
Zealand. None has been made as there are some 15 years stock.
 
--Diphtheria; UK bovine beef muscle and ox heart is used but since the end 
of 1988 this has been sourced from Eire. There are 1,250 litres of stock.
 
--Tetanus; this involves bovine material from the UK mainly Scottish. There 
are 21,000 litres of stock.
 
--Pertussis; uses bovine material from the UK. There are 63,000 litres of 
stock. --They consider that to switch to a non-UK source will take a minimum of 
6-18 months and to switch to a non-bovine source will take a minimum of five 
years.
 
3. XXXXXXXXXXX have measles, mumps, MMR, rubella vaccines. These are 
sourced from the USA and the company believes that US material only is 
used.
 
89/2.14/2.1
 
============
 
BSE3/1 0251
 
4. XXXXXXXXXXX have a measles vaccine using bovine serum from the UK. there 
are 440,000 units of stock. They have also got MMR using bovine serum from the 
UK.
 
5. XXXXXXXXXXX have influenza, rubella, measles,' MMR vaccines likely to be 
used in children. Of those they think that only MMR contains bovine material 
which is probably a French origin.
 
6. XXXXXXXXXXX have diphtheria/tetanus and potasses on clinical trial. hese 
use veal material, some of which has come from the UK and has been ade by 
XXXXXXXXXXX (see above).
 
I have documents of imports from known BSE Countries, of ferments, whole 
blood, antiallergenic preparations,
 
2
 
human blood plasma, normal human blood sera, human immune blood sera, fetal 
bovine serum, and other blood fractions not elsewhere specified or included, 
imported glands, catgut, vaccines for both human/animal, as late as 1998. Let us 
not forget about PITUITARY EXTRACT. This was used to help COWS super ovulate. 
This tissue was considered to be of greatest risk of containing BSE and 
consequently transmitting the disease.
 
ANNEX 6
 
MEETING HELD ON 8 JUNE 1988 TO DISCUSS THE IMPLICATIONS OF BSE TO 
BIOLOGICAL PRODUCTS CONTAINING BOVINE - EXTRACTED MATERIAL
 
How much of this was used in the U.S.?
 
Please do not keep making the same mistakes; 'Absence of evidence is not 
evidence of absence'.
 
What are the U.S. rules for importing and manufacturing vaccines, medicines 
and medical devices?
 
Does the U.S.A. allow sourcing of raw material of ruminants from the 
U.S.A.?
 
U.S. cattle, what kind of guarantee can you give for serum or tissue donor 
herds? . The U.S. rendering system would easily amplify T.S.E.'s:
 
Have we increased the stability of the system (improved heat treatments) 
since the EU SSC report on the U.S.A. was published in july 2000?
 
What is done to avoid cross-contaminations in the U.S.A.?
 
How can the U.S. control absence of cross-contaminations of animal TSE's 
when pig and horse MBM and even deer and elk are allowed in ruminant feed, as 
well as bovine blood? I sadly think of the rendering and feeding policy before 
the Aug. 4, 1997 'partial' feed ban, where anything went, from the city police 
horse, to the circus elephant, i will not mention all the scrapie infected 
sheep. I am surprised that we have not included man 'aka soyent green'. It is a 
disgusting industry and nothing more than greed fuels it.
 
When will the U.S.. start real surveillance of the U.S. bovine population 
(not passive, this will not work)?
 
When will U.S. start removing SRMs?
 
Have they stopped the use of pneumatic stunners in the U.S.?
 
If so, will we stop it in all U.S. abattoirs or only in those abattoirs 
exporting to Europe?
 
If not, WHY NOT?
 
same questions for removal of SRM in the U.S.A., or just for export?
 
If not, WHY NOT?
 
How do we now sterilize surgical/dental instruments in the U.S.A.?
 
Where have we been sourcing surgical catgut?
 
(i have copies of imports to U.S., and it would floor you) hen will 
re-usable surgical instruments be banned?
 
'Unregulated "foods" such as 'nutritional supplements' containing various 
extracts from ruminants, whether imported or derived from
 
3
 
US cattle/sheep/cervids ("antler velvet" extracts!) should be forbidden or 
at least very seriously regulated. (neighbors Mom, whom also died from CJD, had 
been taking bovine based supplement, which contained brain, eye, and many other 
bovine/ovine tissues for years, 'IPLEX').
 
What is the use of banning blood or tissue donors from Germany, France, 
etc... when the U.S.A. continues exposing cattle, sheep and people to SRM, 
refuses to have a serious feed ban, refuses to do systematic 
BSE-surveillance?
 
The FDA should feel responsible for the safety of what people eat, prohibit 
the most dangerous foods, not only prohibit a few more donors - the FDA should 
be responsible for the safe sourcing of medical devices, not only rely on 
banning donors "from Europe", The 'real' risks are here in the U.S. as well, and 
nave been for some time.
 
We must not forget the studies that have proven infectivity in blood from 
TSE's.
 
The Lancet, November 9, 1985
 
Sir, --Professor Manuelidis and his colleagues (Oct 19, p896) report 
transmission to animals of Creutzfeldt-Jakob disease (CJD) from the buffy coat 
from two patients. We also transmitted the disease from, whole blood samples of 
a patient (and of mice) infected with CJD.l Brain, Cornea, and urine from this 
patient were also infectious, and the clinicopathological findings2 are 
summarised as follows.
 
snip...
 
Samples,were taken aseptically at necropsy. 10% crude homogenates of brain 
and cornea in saline, whole blood (after crushing a clot), and untreated CSF and 
urine were innoculated intracerebrally into CFl strain mice (20 ul per animal). 
Some mice showed emaciation, bradykinesia, rigidity of the body and tail, and 
sometimes tremor after long incubation periods. Tissues obtained after the 
animal died (or was killed) were studied histologically (table). Animals 
infected by various inocula showed common pathological changes, consisting of 
severe spongiform changes, glial proliferation, and a moderate loss of nerve 
cells. A few mice inoculated with brain tissue or urine had the same amyloid 
plaques found in patients and animals with CJD.3
 
snip...
 
Department of Neuropathology,. Neurological Institute, Faculty of Medicine, 
Kyushu University, Fukuoka812, Japan JUN TATEISHI
 
(full text-long version)
 
and
 
CWD and transmission to man will be no different than other TSE's.
 
"Clearly, it is premature to draw firm conclusions about CWD passing 
naturally into humans, cattle and sheep, but the present results suggest that 
CWD transmissions to humans would be as limited by PrP incompatibility as 
transmissions of BSE or sheep scrapie to humans. Although there is no evidence 
that sheep scrapie has affected humans, it is likely that BSE has
 
4
 
caused variant CJD in 74 people (definite and probable variant CJD cases to 
date according to the UK CJD Surveillance Unit). Given the presumably large 
number of people exposed to BSE infectivity, the susceptibility of humans may 
still be very low compared with cattle, which would be consistent with the 
relatively inefficient conversion of human PrP-sen by PrPBSE. Nonetheless, since 
humans have apparently been infected by BSE, it would seem prudent to take 
reasonable measures to limit exposure of humans (as well as sheep and cattle) to 
CWD infectivity as has been recommended for other animal TSEs,"
 
G.J. Raymond1, A. Bossers2, L.D. Raymond1, K.I. O'Rourke3, L.E. McHolland4, 
P.K. Bryant III4, M.W. Miller5, E.S. Williams6, M. Smits2 and B. 
Caughey1,7
 
or more recently transmission of BSE to sheep via whole blood Research 
letters Volume 356, Number 9234 16 September 2000
 
Transmission of BSE by blood transfusion in sheep
 
Lancet 2000; 356: 999 – 1000
 
F Houston, J D Foster, Angela Chong, N Hunter, C J Bostock 
 
See Commentary
 
"We have shown that it is possible to transmit bovine spongiform 
encephalopathy (BSE) to a sheep by transfusion with whole blood taken from 
another sheep during the symptom-free phase of an experimental BSE infection. 
BSE and variant Creutzfeldt-Jakob disease (vCJD) in human beings are caused by 
the same infectious agent, and the sheep-BSE experimental model has a similar 
pathogenesis to that of human vCJD. Although UK blood transfusions are 
leucodepleted--a possible protective measure against any risk from blood 
transmission-- this report suggests that blood donated by symptom-free 
vCJD-infected human beings may represent a risk of spread of vCJD infection 
among the human population of the UK."
 
"The demonstration that the new variant of Creutzfeldt-Jakob disease (vCJD) 
is caused by the same agent that causes bovine spongiform encephalopathy (BSE) 
in cattle1 has raised concerns that blood from human beings in the symptom-free 
stages of vCJD could transmit infection to recipients of blood transfusions 
(full text long version)"
 
and...
 
"The large number of cases (1040), temporal clustering of the outbreaks (15 
in the first 6 months of 1997), the high in-flock incidence, and the exceptional 
involvement of goats (390 cases), suggested an accidental infection. The source 
of the epidemic might have been TSE-contaminated meat and bonemeal, but eight 
flocks had never been fed any commercial feedstuff. Infection might have risen 
from the use of a formol-inactivated vaccine against contagious agalactia 
prepared by a single laboratory with brain and mammary gland homogenates of 
sheep infected with Mycoplasma agalactiae. Although clinical signs of TSE in the 
donor sheep have not been found, it is possible that one or more of them were 
harbouring the
 
5
 
infectious agent. Between 1995 and 1996, this vaccine was given 
subcutaneously to 15 of the affected flocks (to one flock in 1994) ; in these 
animals the disease appeared between 23 and 35 months after vaccination. No 
information is available for herd 13 because it was made up of stolen animals. 
Sheep from the remaining three flocks (1-3, figure) did not receive the vaccine, 
thus suggesting a naturally occurring disease.’’ (again, full text long 
version).
 
IN SHORT, please do under estimate this data and or human/animal TSE's 
including CWD in the U.S.A.
 
A few last words, please.
 
The cattle industry would love to have us turn our focus to CWD and forget 
about our own home grown TSE in Bovines. This would be easy to do. Marsh's work 
was from downer cattle feed, NOT downer deer/elk feed. This has been 
proven.
 
DO NOT MAKE THAT MISTAKE.
 
There should be NO LESS THAN 1,000,000 tests for BSE/TSE ' in 2001 for 
U.S.A. French are testing 20,000 a week. The tests are available. Why wait until 
we stumble across a case from passive surveillance, by then it is to late. IF we 
want the truth, this is a must???
 
United States Total ,Bovine Brain Submissions by State,
 
May 10 ,1990 thru October 31, 2000
 
Total 11,700
 
FROM 1.5 BILLION HEAD OF CATTLE since 1990 ???
 
with same feeding and rendering practices as that of U.K. for years and 
years, same scrapie infected sheep used in feed, for years and years, 950 
scrapie infect FLOCKS in the U.S. and over 20 different strains of scrapie known 
to date. (hmmm, i am thinking why there is not a variant scrapie, that is 
totally different than all the rest)? just being sarcastic.
 
with only PARTIAL FEED BAN implemented on Aug. 4, 1997??? (you really need 
to reconsider that blood meal etc. 'TOTAL BAN')
 
 
AND PLEASE FOR GODS SAKE, STOP saying vCJD victims are the only ones tied 
to this environmental death sentence. "PROVE IT". It's just not true. The 
'CHOSEN ONES' are not the only ones dying because of this man-made death 
sentence. When making regulations for human health from human/animal TSEs, you 
had better include ALL human TSE's, not just vCJD. Do NOT underestimate sporadic 
CJD with the 'prehistoric' testing available to date. This could be a deadly 
mistake. Remember, sCJD kills much faster from 1st onset of symptoms to death, 
and hvCJD is the fastest. Could it just be a higher titre of infectivity, or 
route or source, or all three?
 
Last, but not least. The illegal/legal harvesting of body parts and tissues 
will come back to haunt you. Maybe not morally, but due to NO background checks 
and human TSEs, again it will continue to spread.
 
Stupidity, Ignorance and Greed is what fuels this disease. You must stop 
all of this, and ACT AT ONCE... 
 
Sent: Monday, January 08,2001 3:03 PM
 
TO: freas@CBS5055530.CBER.FDA.GOV
 
FDA CJD BSE TSE Prion Scientific Advisors and Consultants Staff January 
2001 Meeting Singeltary Submission
 
2001 FDA CJD TSE Prion Singeltary Submission 
 
 
2001 FDA CJD TSE Prion Singeltary Submission 
 
 
 April 22, 2016 
 
Scrapie Confirmed in a Hartley County Sheep 
 
AUSTIN - Texas Animal Health Commission (TAHC) officials have confirmed 
scrapie in a Hartley County ewe. The ewe was tested by TAHC after the owner 
reported signs of weight loss and lack of coordination to their local 
veterinarian. The premises was quarantined and a flock plan for monitoring is 
being developed by the TAHC and USDA. 
 
"The TAHC is working closely with the flock owner, sharing all of the 
options for disease eradication," said Dr. David Finch, TAHC Region 1 Director. 
"We are thankful the producer was proactive in identifying a problem and seeking 
veterinary help immediately." 
 
Texas leads the nation in sheep and goat production. Since 2008, there have 
been no confirmed cases of scrapie in Texas. The last big spike in Texas scrapie 
cases was in 2006 when nine infected herds were identified and the last herd was 
released from restrictions in 2013. 
 
According to USDA regulations, Texas must conduct adequate scrapie 
surveillance by collecting a minimum of 598 sheep samples annually. Since USDA 
slaughter surveillance started in FY 2003, the percent of cull sheep found 
positive for scrapieat slaughter (once adjusted for face color) has decreased 90 
percent. 
 
Scrapie is the oldest known transmissible spongiform encephalopathies, and 
under natural conditions only sheep and goats are known to be affected by 
scrapie. It is a fatal disease that affects the central nervous system of sheep 
and goats. It is not completely understood how scrapie is passed from one animal 
to the next and apparently healthy sheep infected with scrapie can spread the 
disease. Sheep and goats are typically infected as young lambs or kids, though 
adult sheep and goats can become infected. 
 
The most effective method of scrapie prevention is to maintain a closed 
flock. Raising replacement ewes, purchasing genetically resistant rams and 
ewes,or buying from a certified-free scrapie flock are other options to reduce 
the risk of scrapie. At this time the resistant genetic markers in goats have 
not been identified, therefore it is important to maintain your sheep and goat 
herds separately. 
 
The incubation period for Scrapie is typically two to five years. Producers 
should record individual identification numbers and the seller's premise 
identification number on purchase and sales records. These records must be 
maintained for a minimum of five years. 
 
Producers should notify the Texas Animal Health Commission (800-550-8242) 
or the USDA-Austin Office (512-383-2400) if they have an adult sheep or goat 
with neurologic signs such as incoordination, behavioral changes, or intense 
itching with wool loss. Producers may order scrapie identification tags by 
calling 866-873-2824. For more information, please visit our website at: 
 
 
### 
 
 
Texas Scrapie Confirmed in a Hartley County Sheep where CWD was detected in 
a Mule Deer, was there a link to the two ??? 
 
Sunday, May 22, 2016 
 
TEXAS CWD DEER BREEDERS PLEA TO GOVERNOR ABBOTT TO CIRCUMVENT TPWD SOUND 
SCIENCE TO LET DISEASE SPREAD 
 
 
Prion. 10:S15-S21. 2016 ISSN: 1933-6896 printl 1933-690X online
 
Taylor & Francis
 
Prion 2016 Animal Prion Disease Workshop Abstracts
 
WS-01: Prion diseases in animals and zoonotic potential
 
Juan Maria Torres a, Olivier Andreoletti b, J uan-Carlos Espinosa a. 
Vincent Beringue c. Patricia Aguilar a,
 
Natalia Fernandez-Borges a. and Alba Marin-Moreno a
 
"Centro de Investigacion en Sanidad Animal ( CISA-INIA ). Valdeolmos, 
Madrid. Spain; b UMR INRA -ENVT 1225 Interactions Holes Agents Pathogenes. ENVT. 
Toulouse. France: "UR892. Virologie lmmunologie MolécuIaires, Jouy-en-Josas. 
France
 
Dietary exposure to bovine spongiform encephalopathy (BSE) contaminated 
bovine tissues is considered as the origin of variant Creutzfeldt Jakob (vCJD) 
disease in human. To date, BSE agent is the only recognized zoonotic prion. 
Despite the variety of Transmissible Spongiform Encephalopathy (TSE) agents that 
have been circulating for centuries in farmed ruminants there is no apparent 
epidemiological link between exposure to ruminant products and the occurrence of 
other form of TSE in human like sporadic Creutzfeldt Jakob Disease (sCJD). 
However, the zoonotic potential of the diversity of circulating TSE agents has 
never been systematically assessed. The major issue in experimental assessment 
of TSEs zoonotic potential lies in the modeling of the ‘species barrier‘, the 
biological phenomenon that limits TSE agents’ propagation from a species to 
another. In the last decade, mice genetically engineered to express normal forms 
of the human prion protein has proved essential in studying human prions 
pathogenesis and modeling the capacity of TSEs to cross the human species 
barrier.
 
To assess the zoonotic potential of prions circulating in farmed ruminants, 
we study their transmission ability in transgenic mice expressing human PrPC 
(HuPrP-Tg). Two lines of mice expressing different forms of the human PrPC 
(129Met or 129Val) are used to determine the role of the Met129Val dimorphism in 
susceptibility/resistance to the different agents.
 
These transmission experiments confirm the ability of BSE prions to 
propagate in 129M- HuPrP-Tg mice and demonstrate that Met129 homozygotes may be 
susceptible to BSE in sheep or goat to a greater degree than the BSE agent in 
cattle and that these agents can convey molecular properties and 
neuropathological indistinguishable from vCJD. However homozygous 129V mice are 
resistant to all tested BSE derived prions independently of the originating 
species suggesting a higher transmission barrier for 129V-PrP variant.
 
Transmission data also revealed that several scrapie prions propagate in 
HuPrP-Tg mice with efficiency comparable to that of cattle BSE. While the 
efficiency of transmission at primary passage was low, subsequent passages 
resulted in a highly virulent prion disease in both Met129 and Val129 mice. 
Transmission of the different scrapie isolates in these mice leads to the 
emergence of prion strain phenotypes that showed similar characteristics to 
those displayed by MM1 or VV2 sCJD prion. These results demonstrate that scrapie 
prions have a zoonotic potential and raise new questions about the possible link 
between animal and human prions.
 
 
Research Project: TRANSMISSION, DIFFERENTIATION, AND PATHOBIOLOGY OF 
TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES 
 
Title: Transmission of scrapie prions to primate after an extended silent 
incubation period 
 
Authors 
 
item Comoy, Emmanuel - item Mikol, Jacqueline - item Luccantoni-Freire, 
Sophie - item Correia, Evelyne - item Lescoutra-Etchegaray, Nathalie - item 
Durand, Valérie - item Dehen, Capucine - item Andreoletti, Olivier - item 
Casalone, Cristina - item Richt, Juergen item Greenlee, Justin item Baron, 
Thierry - item Benestad, Sylvie - item Hills, Bob - item Brown, Paul - item 
Deslys, Jean-Philippe - 
 
Submitted to: Scientific Reports Publication Type: Peer Reviewed Journal 
Publication Acceptance Date: May 28, 2015 Publication Date: June 30, 2015 
Citation: Comoy, E.E., Mikol, J., Luccantoni-Freire, S., Correia, E., 
Lescoutra-Etchegaray, N., Durand, V., Dehen, C., Andreoletti, O., Casalone, C., 
Richt, J.A., Greenlee, J.J., Baron, T., Benestad, S., Brown, P., Deslys, J. 
2015. Transmission of scrapie prions to primate after an extended silent 
incubation period. Scientific Reports. 5:11573. 
 
Interpretive Summary: The transmissible spongiform encephalopathies (also 
called prion diseases) are fatal neurodegenerative diseases that affect animals 
and humans. The agent of prion diseases is a misfolded form of the prion protein 
that is resistant to breakdown by the host cells. Since all mammals express 
prion protein on the surface of various cells such as neurons, all mammals are, 
in theory, capable of replicating prion diseases. One example of a prion 
disease, bovine spongiform encephalopathy (BSE; also called mad cow disease), 
has been shown to infect cattle, sheep, exotic undulates, cats, non-human 
primates, and humans when the new host is exposed to feeds or foods contaminated 
with the disease agent. The purpose of this study was to test whether non-human 
primates (cynomologous macaque) are susceptible to the agent of sheep scrapie. 
After an incubation period of approximately 10 years a macaque developed 
progressive clinical signs suggestive of neurologic disease. Upon postmortem 
examination and microscopic examination of tissues, there was a widespread 
distribution of lesions consistent with a transmissible spongiform 
encephalopathy. This information will have a scientific impact since it is the 
first study that demonstrates the transmission of scrapie to a non-human primate 
with a close genetic relationship to humans. This information is especially 
useful to regulatory officials and those involved with risk assessment of the 
potential transmission of animal prion diseases to humans. Technical Abstract: 
Classical bovine spongiform encephalopathy (c-BSE) is an animal prion disease 
that also causes variant Creutzfeldt-Jakob disease in humans. Over the past 
decades, c-BSE's zoonotic potential has been the driving force in establishing 
extensive protective measures for animal and human health. 
 
*** In complement to the recent demonstration that humanized mice are 
susceptible to scrapie, we report here the first observation of direct 
transmission of a natural classical scrapie isolate to a macaque after a 10-year 
incubation period. Neuropathologic examination revealed all of the features of a 
prion disease: spongiform change, neuronal loss, and accumulation of PrPres 
throughout the CNS. 
 
*** This observation strengthens the questioning of the harmlessness of 
scrapie to humans, at a time when protective measures for human and animal 
health are being dismantled and reduced as c-BSE is considered controlled and 
being eradicated. 
 
*** Our results underscore the importance of precautionary and protective 
measures and the necessity for long-term experimental transmission studies to 
assess the zoonotic potential of other animal prion strains. 
 
 
2015
 
O.05: Transmission of prions to primates after extended silent incubation 
periods: Implications for BSE and scrapie risk assessment in human populations 
 
Emmanuel Comoy, Jacqueline Mikol, Valerie Durand, Sophie Luccantoni, 
Evelyne Correia, Nathalie Lescoutra, Capucine Dehen, and Jean-Philippe Deslys 
Atomic Energy Commission; Fontenay-aux-Roses, France 
 
Prion diseases (PD) are the unique neurodegenerative proteinopathies 
reputed to be transmissible under field conditions since decades. The 
transmission of Bovine Spongiform Encephalopathy (BSE) to humans evidenced that 
an animal PD might be zoonotic under appropriate conditions. Contrarily, in the 
absence of obvious (epidemiological or experimental) elements supporting a 
transmission or genetic predispositions, PD, like the other proteinopathies, are 
reputed to occur spontaneously (atpical animal prion strains, sporadic CJD 
summing 80% of human prion cases). Non-human primate models provided the first 
evidences supporting the transmissibiity of human prion strains and the zoonotic 
potential of BSE. Among them, cynomolgus macaques brought major information for 
BSE risk assessment for human health (Chen, 2014), according to their 
phylogenetic proximity to humans and extended lifetime. We used this model to 
assess the zoonotic potential of other animal PD from bovine, ovine and cervid 
origins even after very long silent incubation periods. 
 
*** We recently observed the direct transmission of a natural classical 
scrapie isolate to macaque after a 10-year silent incubation period, 
 
***with features similar to some reported for human cases of sporadic CJD, 
albeit requiring fourfold long incubation than BSE. Scrapie, as recently evoked 
in humanized mice (Cassard, 2014), 
 
***is the third potentially zoonotic PD (with BSE and L-type BSE), 
 
***thus questioning the origin of human sporadic cases. We will present an 
updated panorama of our different transmission studies and discuss the 
implications of such extended incubation periods on risk assessment of animal PD 
for human health. 
 
=============== 
 
***thus questioning the origin of human sporadic cases*** 
 
=============== 
 
***our findings suggest that possible transmission risk of H-type BSE to 
sheep and human. Bioassay will be required to determine whether the PMCA 
products are infectious to these animals. 
 
============== 
 
 
Tuesday, December 16, 2014 
 
*** Evidence for zoonotic potential of ovine scrapie prions 
 
Hervé Cassard,1, n1 Juan-Maria Torres,2, n1 Caroline Lacroux,1, Jean-Yves 
Douet,1, Sylvie L. Benestad,3, Frédéric Lantier,4, Séverine Lugan,1, Isabelle 
Lantier,4, Pierrette Costes,1, Naima Aron,1, Fabienne Reine,5, Laetitia 
Herzog,5, Juan-Carlos Espinosa,2, Vincent Beringue5, & Olivier Andréoletti1, 
Affiliations Contributions Corresponding author Journal name: Nature 
Communications Volume: 5, Article number: 5821 DOI: doi:10.1038/ncomms6821 
Received 07 August 2014 Accepted 10 November 2014 Published 16 December 2014 
Article tools Citation Reprints Rights & permissions Article metrics 
 
Abstract 
 
Although Bovine Spongiform Encephalopathy (BSE) is the cause of variant 
Creutzfeldt Jakob disease (vCJD) in humans, the zoonotic potential of scrapie 
prions remains unknown. Mice genetically engineered to overexpress the human 
prion protein (tgHu) have emerged as highly relevant models for gauging the 
capacity of prions to transmit to humans. These models can propagate human 
prions without any apparent transmission barrier and have been used used to 
confirm the zoonotic ability of BSE. Here we show that a panel of sheep scrapie 
prions transmit to several tgHu mice models with an efficiency comparable to 
that of cattle BSE. 
 
***The serial transmission of different scrapie isolates in these mice led 
to the propagation of prions that are phenotypically identical to those causing 
sporadic CJD (sCJD) in humans. 
 
***These results demonstrate that scrapie prions have a zoonotic potential 
and raise new questions about the possible link between animal and human prions. 
 
Subject terms: Biological sciences• Medical research At a glance 
 
 
see more here ; 
 
 
***The serial transmission of different scrapie isolates in these mice led 
to the propagation of prions that are phenotypically identical to those causing 
sporadic CJD (sCJD) in humans.*** 
 
***These results demonstrate that scrapie prions have a zoonotic potential 
and raise new questions about the possible link between animal and human 
prions.*** 
 
why do we not want to do TSE transmission studies on chimpanzees $ 
 
5. A positive result from a chimpanzee challenged severly would likely 
create alarm in some circles even if the result could not be interpreted for 
man. I have a view that all these agents could be transmitted provided a large 
enough dose by appropriate routes was given and the animals kept long enough. 
Until the mechanisms of the species barrier are more clearly understood it might 
be best to retain that hypothesis. 
 
snip... 
 
R. BRADLEY 
 
 
1: J Infect Dis 1980 Aug;142(2):205-8 
 
Oral transmission of kuru, Creutzfeldt-Jakob disease, and scrapie to 
nonhuman primates. 
 
Gibbs CJ Jr, Amyx HL, Bacote A, Masters CL, Gajdusek DC. 
 
Kuru and Creutzfeldt-Jakob disease of humans and scrapie disease of sheep 
and goats were transmitted to squirrel monkeys (Saimiri sciureus) that were 
exposed to the infectious agents only by their nonforced consumption of known 
infectious tissues. The asymptomatic incubation period in the one monkey exposed 
to the virus of kuru was 36 months; that in the two monkeys exposed to the virus 
of Creutzfeldt-Jakob disease was 23 and 27 months, respectively; and that in the 
two monkeys exposed to the virus of scrapie was 25 and 32 months, respectively. 
Careful physical examination of the buccal cavities of all of the monkeys failed 
to reveal signs or oral lesions. One additional monkey similarly exposed to kuru 
has remained asymptomatic during the 39 months that it has been under 
observation. 
 
snip... 
 
The successful transmission of kuru, Creutzfeldt-Jakob disease, and scrapie 
by natural feeding to squirrel monkeys that we have reported provides further 
grounds for concern that scrapie-infected meat may occasionally give rise in 
humans to Creutzfeldt-Jakob disease. 
 
PMID: 6997404 
 
 
Recently the question has again been brought up as to whether scrapie is 
transmissible to man. This has followed reports that the disease has been 
transmitted to primates. One particularly lurid speculation (Gajdusek 1977) 
conjectures that the agents of scrapie, kuru, Creutzfeldt-Jakob disease and 
transmissible encephalopathy of mink are varieties of a single "virus". The U.S. 
Department of Agriculture concluded that it could "no longer justify or permit 
scrapie-blood line and scrapie-exposed sheep and goats to be processed for human 
or animal food at slaughter or rendering plants" (ARC 84/77)" The problem is 
emphasised by the finding that some strains of scrapie produce lesions identical 
to the once which characterise the human dementias" 
 
Whether true or not. the hypothesis that these agents might be 
transmissible to man raises two considerations. First, the safety of laboratory 
personnel requires prompt attention. Second, action such as the "scorched meat" 
policy of USDA makes the solution of the acrapie problem urgent if the sheep 
industry is not to suffer grievously. 
 
snip... 
 
76/10.12/4.6 
 
 
Nature. 1972 Mar 10;236(5341):73-4. 
 
Transmission of scrapie to the cynomolgus monkey (Macaca fascicularis). 
 
Gibbs CJ Jr, Gajdusek DC. 
 
Nature 236, 73 - 74 (10 March 1972); doi:10.1038/236073a0 
 
Transmission of Scrapie to the Cynomolgus Monkey (Macaca fascicularis) 
 
C. J. GIBBS jun. & D. C. GAJDUSEK 
 
National Institute of Neurological Diseases and Stroke, National Institutes 
of Health, Bethesda, Maryland 
 
SCRAPIE has been transmitted to the cynomolgus, or crab-eating, monkey 
(Macaca fascicularis) with an incubation period of more than 5 yr from the time 
of intracerebral inoculation of scrapie-infected mouse brain. The animal 
developed a chronic central nervous system degeneration, with ataxia, tremor and 
myoclonus with associated severe scrapie-like pathology of intensive astroglial 
hypertrophy and proliferation, neuronal vacuolation and status spongiosus of 
grey matter. The strain of scrapie virus used was the eighth passage in Swiss 
mice (NIH) of a Compton strain of scrapie obtained as ninth intracerebral 
passage of the agent in goat brain, from Dr R. L. Chandler (ARC, Compton, 
Berkshire). 
 
 
 
Saturday, April 23, 2016 
 
SCRAPIE WS-01: Prion diseases in animals and zoonotic potential 2016 
 
Prion. 10:S15-S21. 2016 ISSN: 1933-6896 printl 1933-690X online
 
 
*** Docket No. APHIS-2007-0127 Scrapie in Sheep and Goats Terry Singeltary 
Sr. Submission ***
 
Docket No. APHIS-2007-0127 Scrapie in Sheep and Goats
 
SUMMARY: We are reopening the comment period for our proposed rule that 
would revise completely the scrapie regulations, which concern the risk groups 
and categories established for individual animals and for flocks, the use of 
genetic testing as a means of assigning risk levels to animals, movement 
restrictions for animals found to be genetically less susceptible or resistant 
to scrapie, and recordkeeping requirements. This action will allow interested 
persons additional time to prepare and submit comments.DATES: The comment period 
for the proposed rule published on September 10, 2015 (80 FR 54660-54692) is 
reopened. We will consider all comments that we receive on or before December 9, 
2015. ...
 
 
 
 
Comment from Terry Singeltary This is a Comment on the Animal and Plant 
Health Inspection Service (APHIS) Proposed Rule: Scrapie in Sheep and 
Goats
 
For related information, Open Docket Folder Docket folder icon 
 
--------------------------------------------------------------------------------
 
Show agency attachment(s) AttachmentsView All (0) 
 
--------------------------------------------------------------------------------
 
Comment View document:Indeed, much science has changed about the Scrapie 
TSE prion, including more science linking Scrapie to humans. sadly, politics, 
industry, and trade, have not changed, and those usually trump sound science, as 
is the case with all Transmissible Spongiform Encephalopathy TSE Prion disease 
in livestock producing animals and the OIE. we can look no further at the legal 
trading of the Scrapie TSE prion both typical and atypical of all strains, and 
CWD all stains. With as much science of old, and now more new science to back 
this up, Scrapie of all types i.e. atypical and typical, BSE all strains, and 
CWD all strains, should be regulated in trade as BSE TSE PRION. In fact, I urge 
APHIS et al and the OIE, and all trading partners to take heed to the latest 
science on the TSE prion disease, all of them, and seriously reconsider the 
blatant disregards for human and animal health, all in the name of trade, with 
the continued relaxing of TSE Prion trade regulations through the 'NEGLIGIBLE 
BSE RISK' PROGRAM, which was set up to fail in the first place. If the world 
does not go back to the 'BSE RISK ASSESSMENTS', enhance, and or change that 
assessment process to include all TSE prion disease, i.e. 'TSE RISK ASSESSMENT', 
if we do not do this and if we continue this farce with OIE and the USDA et al, 
and the 'NEGLIGIBLE BSE RISK' PROGRAM, we will never eradicate the TSE prion aka 
mad cow type disease, they will continue to mutate and spread among species of 
human and animal origin, and they will continue to kill. ...
 
please see ;
 
O.05: Transmission of prions to primates after extended silent incubation 
periods: Implications for BSE and scrapie risk assessment in human populations 
 
Emmanuel Comoy, Jacqueline Mikol, Valerie Durand, Sophie Luccantoni, 
Evelyne Correia, Nathalie Lescoutra, Capucine Dehen, and Jean-Philippe Deslys 
Atomic Energy Commission; Fontenay-aux-Roses, France 
 
Prion diseases (PD) are the unique neurodegenerative proteinopathies 
reputed to be transmissible under field conditions since decades. The 
transmission of Bovine Spongiform Encephalopathy (BSE) to humans evidenced that 
an animal PD might be zoonotic under appropriate conditions. Contrarily, in the 
absence of obvious (epidemiological or experimental) elements supporting a 
transmission or genetic predispositions, PD, like the other proteinopathies, are 
reputed to occur spontaneously (atpical animal prion strains, sporadic CJD 
summing 80% of human prion cases). Non-human primate models provided the first 
evidences supporting the transmissibiity of human prion strains and the zoonotic 
potential of BSE. Among them, cynomolgus macaques brought major information for 
BSE risk assessment for human health (Chen, 2014), according to their 
phylogenetic proximity to humans and extended lifetime. We used this model to 
assess the zoonotic potential of other animal PD from bovine, ovine and cervid 
origins even after very long silent incubation periods. 
 
*** We recently observed the direct transmission of a natural classical 
scrapie isolate to macaque after a 10-year silent incubation period, 
 
***with features similar to some reported for human cases of sporadic CJD, 
albeit requiring fourfold longe incubation than BSE. Scrapie, as recently evoked 
in humanized mice (Cassard, 2014), 
 
***is the third potentially zoonotic PD (with BSE and L-type BSE), 
 
***thus questioning the origin of human sporadic cases. We will present an 
updated panorama of our different transmission studies and discuss the 
implications of such extended incubation periods on risk assessment of animal PD 
for human health.
 
===============
 
***thus questioning the origin of human sporadic cases***
 
=============== 
 
 
***This information will have a scientific impact since it is the first 
study that demonstrates the transmission of scrapie to a non-human primate with 
a close genetic relationship to humans. This information is especially useful to 
regulatory officials and those involved with risk assessment of the potential 
transmission of animal prion diseases to humans. 
 
***This observation strengthens the questioning of the harmlessness of 
scrapie to humans, at a time when protective measures for human and animal 
health are being dismantled and reduced as c-BSE is considered controlled and 
being eradicated. Our results underscore the importance of precautionary and 
protective measures and the necessity for long-term experimental transmission 
studies to assess the zoonotic potential of other animal prion strains. 
 
 
please see file attachment for full submission and recent science and my 
deep concerns on the TSE Prion disease... No documents available. 
AttachmentsView All (1) scrapie-usa-blogspot-com View Attachment: 
 
 
CWD to CJD in humans (why not?), as easy as BSE/Scrapie;
 
The EMBO Journal, Vol. 19, No. 17 pp. 4425-4430, 2000
 
© European Molecular Biology Organization
 
Evidence of a molecular barrier limiting susceptibility of humans, cattle 
and sheep to chronic wasting disease
 
G.J. Raymond1, A. Bossers2, L.D. Raymond1, K.I. O?Rourke3,
 
L.E. McHolland4, P.K. Bryant III4, M.W. Miller5, E.S. Williams6, M.
 
Smits2
 
and B. Caughey1,7
 
1NIAID/NIH Rocky Mountain Laboratories, Hamilton, MT 59840,
 
3USDA/ARS/ADRU, Pullman, WA 99164-7030, 4USDA/ARS/ABADRL,
 
Laramie, WY 82071, 5Colorado Division of Wildlife, Wildlife Research
 
Center, Fort Collins, CO 80526-2097, 6Department of Veterinary 
Sciences,
 
University of Wyoming, Laramie, WY 82070, USA and 2ID-Lelystad,
 
Institute for Animal Science and Health, Lelystad, The Netherlands
 
7Corresponding author e-mail: bcaughey@nih.gov Received June 7, 2000; 
 
revised July 3, 2000; accepted July 5, 2000.
 
Abstract
 
Chronic wasting disease (CWD) is a transmissible spongiform encephalopathy 
(TSE) of deer and elk, and little is known about its transmissibility to other 
species. An important factor controlling interspecies TSE susceptibility is 
prion protein (PrP) homology between the source and recipient species/genotypes. 
Furthermore, the efficiency with which the protease-resistant PrP (PrP-res) of 
one species induces the in vitro conversion of the normal PrP (PrP-sen) of 
another species to the protease-resistant state correlates with the 
cross-species transmissibility of TSE agents. Here we show that the 
CWD-associated PrP-res (PrPCWD) of cervids readily induces the conversion of 
recombinant cervid PrP-sen molecules to the protease-resistant state in 
accordance with the known transmissibility of CWD between cervids. In contrast, 
PrPCWD-induced conversions of human and bovine PrP-sen were much less efficient, 
and conversion of ovine PrP-sen was intermediate. These results demonstrate a 
barrier at the molecular level that should limit the susceptibility of these 
non-cervid species to CWD.
 
snip...
 
Clearly, it is premature to draw firm conclusions about CWD passing 
naturally into humans, cattle and sheep, but the present results suggest that 
CWD transmissions to humans would be as limited by PrP incompatibility as 
transmissions of BSE or sheep scrapie to humans. Although there is no evidence 
that sheep scrapie has affected humans, it is likely that BSE has caused variant 
CJD in 74 people (definite and probable variant CJD cases to date according to 
the UK CJD Surveillance Unit). Given the presumably large number of people 
exposed to BSE infectivity, the susceptibility of humans may still be very low 
compared with cattle, which would be consistent with the relatively inefficient 
conversion of human PrP-sen by PrPBSE. Nonetheless, since humans have apparently 
been infected by BSE, it would seem prudent to take reasonable measures to limit 
exposure of humans (as well as sheep and cattle) to CWD infectivity as has been 
recommended for other animal TSEs.
 
snip...
 
 
Scrapie to Humans USA?
 
1: Neuroepidemiology. 1985;4(4):240-9. Related Articles,
 
Links 
 
Sheep consumption: a possible source of spongiform encephalopathy in 
humans.
 
Davanipour Z, Alter M, Sobel E, Callahan M.
 
A fatal spongiform encephalopathy of sheep and goats (scrapie) shares many 
characteristics with Creutzfeldt-Jakob disease (CJD), a similar dementing 
illness of humans. To investigate the possibility that CJD is acquired by 
ingestion of contaminated sheep products, we collected information on 
production, slaughtering practices, and marketing of sheep in Pennsylvania. The 
study revealed that sheep were usually marketed before central nervous system 
signs of scrapie are expected to appear; breeds known to be susceptible to the 
disease were the most common breeds raised in the area; sheep were imported from 
other states including those with a high frequency of scrapie; use of veterinary 
services on the sheep farms investigated and, hence, opportunities to detect the 
disease were limited; sheep producers in the area knew little about scrapie 
despite the fact that the disease has been reported in the area, and animal 
organs including sheep organs were sometimes included in processed food. 
Therefore, it was concluded that in Pennsylvania there are some 'weak links' 
through which scrapie-infected animals could contaminate human food, and that 
consumption of these foods could perhaps account for spongiform encephalopathy 
in humans. The weak links observed are probably not unique to 
Pennsylvania.
 
PMID: 3915057 [PubMed - indexed for MEDLINE] 
 
 
Saturday, July 6, 2013 
 
*** Small Ruminant Nor98 Prions Share Biochemical Features with Human 
Gerstmann-Sträussler-Scheinker Disease and Variably Protease-Sensitive 
Prionopathy 
 
Research Article 
 
 
Monday, December 14, 2009
 
Similarities between Forms of Sheep Scrapie and Creutzfeldt-Jakob Disease 
Are Encoded by Distinct Prion Types
 
(hmmm, this is getting interesting now...TSS)
 
Sporadic CJD type 1 and atypical/ Nor98 scrapie are characterized by fine 
(reticular) deposits,
 
see also ;
 
All of the Heidenhain variants were of the methionine/ methionine type 1 
molecular subtype. 
 
 
see full text ;
 
Monday, December 14, 2009
 
Similarities between Forms of Sheep Scrapie and Creutzfeldt-Jakob Disease 
Are Encoded by Distinct Prion Types
 
 
Suspect symptoms
 
What if you can catch old-fashioned CJD by eating meat from a sheep 
infected with scrapie?
 
28 Mar 01 Most doctors believe that sCJD is caused by a prion protein 
deforming by chance into a killer. But Singeltary thinks otherwise. He is one of 
a number of campaigners who say that some sCJD, like the variant CJD related to 
BSE, is caused by eating meat from infected animals. Their suspicions have 
focused on sheep carrying scrapie, a BSE-like disease that is widespread in 
flocks across Europe and North America.
 
Now scientists in France have stumbled across new evidence that adds weight 
to the campaigners' fears. To their complete surprise, the researchers found 
that one strain of scrapie causes the same brain damage in mice as sCJD.
 
"This means we cannot rule out that at least some sCJD may be caused by 
some strains of scrapie," says team member Jean-Philippe Deslys of the French 
Atomic Energy Commission's medical research laboratory in Fontenay-aux-Roses, 
south-west of Paris. Hans Kretschmar of the University of Göttingen, who 
coordinates CJD surveillance in Germany, is so concerned by the findings that he 
now wants to trawl back through past sCJD cases to see if any might have been 
caused by eating infected mutton or lamb...
 
2001
 
Suspect symptoms 
 
What if you can catch old-fashioned CJD by eating meat from a sheep 
infected with scrapie? 
 
28 Mar 01 
 
Like lambs to the slaughter 
 
31 March 2001 
 
by Debora MacKenzie Magazine issue 2284. 
 
FOUR years ago, Terry Singeltary watched his mother die horribly from a 
degenerative brain disease. Doctors told him it was Alzheimer's, but Singeltary 
was suspicious. The diagnosis didn't fit her violent symptoms, and he demanded 
an autopsy. It showed she had died of sporadic Creutzfeldt-Jakob disease.
 
Most doctors believe that sCJD is caused by a prion protein deforming by 
chance into a killer. But Singeltary thinks otherwise. He is one of a number of 
campaigners who say that some sCJD, like the variant CJD related to BSE, is 
caused by eating meat from infected animals. Their suspicions have focused on 
sheep carrying scrapie, a BSE-like disease that is widespread in flocks across 
Europe and North America.
 
Now scientists in France have stumbled across new evidence that adds weight 
to the campaigners' fears. To their complete surprise, the researchers found 
that one strain of scrapie causes the same brain damage in mice as sCJD.
 
"This means we cannot rule out that at least some sCJD may be caused by 
some strains of scrapie," says team member Jean-Philippe Deslys of the French 
Atomic Energy Commission's medical research laboratory in Fontenay-aux-Roses, 
south-west of Paris. Hans Kretschmar of the University of Göttingen, who 
coordinates CJD surveillance in Germany, is so concerned by the findings that he 
now wants to trawl back through past sCJD cases to see if any might have been 
caused by eating infected mutton or lamb.
 
Scrapie has been around for centuries and until now there has been no 
evidence that it poses a risk to human health. But if the French finding means 
that scrapie can cause sCJD in people, countries around the world may have 
overlooked a CJD crisis to rival that caused by BSE.
 
Deslys and colleagues were originally studying vCJD, not sCJD. They 
injected the brains of macaque monkeys with brain from BSE cattle, and from 
French and British vCJD patients. The brain damage and clinical symptoms in the 
monkeys were the same for all three. Mice injected with the original sets of 
brain tissue or with infected monkey brain also developed the same 
symptoms.
 
As a control experiment, the team also injected mice with brain tissue from 
people and animals with other prion diseases: a French case of sCJD; a French 
patient who caught sCJD from human-derived growth hormone; sheep with a French 
strain of scrapie; and mice carrying a prion derived from an American scrapie 
strain. As expected, they all affected the brain in a different way from BSE and 
vCJD. But while the American strain of scrapie caused different damage from 
sCJD, the French strain produced exactly the same pathology.
 
"The main evidence that scrapie does not affect humans has been 
epidemiology," says Moira Bruce of the neuropathogenesis unit of the Institute 
for Animal Health in Edinburgh, who was a member of the same team as Deslys. 
"You see about the same incidence of the disease everywhere, whether or not 
there are many sheep, and in countries such as New Zealand with no scrapie." In 
the only previous comparisons of sCJD and scrapie in mice, Bruce found they were 
dissimilar.
 
But there are more than 20 strains of scrapie, and six of sCJD. "You would 
not necessarily see a relationship between the two with epidemiology if only 
some strains affect only some people," says Deslys. Bruce is cautious about the 
mouse results, but agrees they require further investigation. Other trials of 
scrapie and sCJD in mice, she says, are in progress.
 
People can have three different genetic variations of the human prion 
protein, and each type of protein can fold up two different ways. Kretschmar has 
found that these six combinations correspond to six clinical types of sCJD: each 
type of normal prion produces a particular pathology when it spontaneously 
deforms to produce sCJD.
 
But if these proteins deform because of infection with a disease-causing 
prion, the relationship between pathology and prion type should be different, as 
it is in vCJD. "If we look at brain samples from sporadic CJD cases and find 
some that do not fit the pattern," says Kretschmar, "that could mean they were 
caused by infection."
 
There are 250 deaths per year from sCJD in the US, and a similar incidence 
elsewhere. Singeltary and other US activists think that some of these people 
died after eating contaminated meat or "nutritional" pills containing dried 
animal brain. Governments will have a hard time facing activists like Singeltary 
if it turns out that some sCJD isn't as spontaneous as doctors have 
insisted.
 
Deslys's work on macaques also provides further proof that the human 
disease vCJD is caused by BSE. And the experiments showed that vCJD is much more 
virulent to primates than BSE, even when injected into the bloodstream rather 
than the brain. This, says Deslys, means that there is an even bigger risk than 
we thought that vCJD can be passed from one patient to another through 
contaminated blood transfusions and surgical instruments.
 
 
Then follow up with PNAS studies from which new scientist article written 
from; 
 
Adaptation of the bovine spongiform encephalopathy agent to primates and 
comparison with Creutzfeldt- Jakob disease: Implications for human health 
 
THE findings from Corinne Ida Lasmézas*, [dagger] , Jean-Guy Fournier*, 
Virginie Nouvel*,
 
Hermann Boe*, Domíníque Marcé*, François Lamoury*, Nicolas Kopp 
[Dagger
 
] , Jean-Jacques Hauw§, James Ironside¶, Moira Bruce [||] , Dominique
 
Dormont*, and Jean-Philippe Deslys* et al, that The agent responsible for 
French iatrogenic growth hormone-linked CJD taken as a control is very different 
from vCJD but is similar to that found in one case of sporadic CJD and one sheep 
scrapie isolate;
 
 
 Comment from Terry Singeltary Sr. 
 
 This is a Comment on the Animal and Plant Health Inspection Service 
(APHIS) Notice: Agency Information Collection Activities; Proposals, 
Submissions, and Approvals: Bovine Spongiform Encephalopathy; Importation of 
Animals and Animal Products 
 
 Docket No. APHIS-2014-0107 Bovine Spongiform Encephalopathy; Importation 
of Animals and Animal Products Singeltary Submission ; 
 
 AttachmentsView All (1) 
 
 Docket No. APHIS-2014-0107 Bovine Spongiform Encephalopathy; Importation 
of Animals and Animal Products Singeltary Submission View Attachment: 
 
 
 Comment 
 
 Subject: BSE; MRR; IMPORTATION OF LIVE BOVINES AND PRODUCTS DERIVED FROM 
BOVINES [Docket No. APHIS-2006-0041] RIN 0579-AC01 
 
 Date: January 9, 2007 at 9:08 am PST 
 
 
 Owens, Julie 
 
 Terry S. Singeltary Sr. 
 
 Sent: Monday, July 24, 2006 1:09 PM 
 
 To: FSIS RegulationsComments 
 
 Subject: [Docket No. FSIS-2006-0011] FSIS Harvard Risk Assessment of 
Bovine Spongiform Encephalopathy (BSE) Page 1 of 98 
 
 
 Comment from Terry S Singletary 
 
 This is a Comment on the Animal and Plant Health Inspection Service 
(APHIS) 
 
 Proposed Rule: Bovine Spongiform Encephalopathy; Minimal-Risk Regions, 
Identification of Ruminants and Processing and Importation of Commodities 
 
 For related information, Open Docket Folder Docket folder icon 
 
 Comment 
 
 see full text ; 
 
 
 FSIS, USDA, REPLY TO SINGELTARY 
 
 
 Comment from Terry Singeltary 
 
 This is a Comment on the Food and Drug Administration (FDA) Notice: Draft 
Guidance for Industry on Ensuring Safety of Animal Feed Maintained and Fed 
On-Farm; Availability 
 
 For related information, Open Docket Folder Docket folder icon 
 
 
 Comment from Terry Singeltary 
 
 This is a Comment on the Animal and Plant Health Inspection Service 
(APHIS) Notice: Environmental Impact Statements; Availability, etc.: Animal 
Carcass Management 
 
 
 Comment from Terry Singeltary 
 
 This is a Comment on the Animal and Plant Health Inspection Service 
(APHIS) Proposed Rule: Scrapie in Sheep and Goats 
 
 For related information, Open Docket Folder Docket folder icon 
 
 please see ; 
 
 AttachmentsView All (1) scrapie-usa-blogspot-com View Attachment: 
 
 
 Comment from Terry S. Singeltary Sr. 
 
 This is a Comment on the Food and Drug Administration (FDA) Notice: 
 
 Risk Assessment of Foodborne Illness Associated With Pathogens From 
Produce Grown in Fields Amended With Untreated Biological Soil Amendments of 
Animal Origin; Request for Scientific Data, Information, and Comments 
 
 
 Comment from Terry Singeltary 
 
 This is a Comment on the Animal and Plant Health Inspection Service 
(APHIS) 
 
 Notice: Program Standards: Chronic Wasting Disease Herd Certification 
Program and Interstate Movement of Farmed or Captive Deer, Elk, and Moose 
 
 Comment 
 
 Docket No. 00-108-10 Chronic Wasting Disease Herd Certification Program 
and Interstate Movement of Farmed or Captive Deer, Elk, and Moose; Program 
Standards 
 
 >>>The CWD herd certification program is a voluntary, cooperative 
program that establishes minimum requirements for the interstate movement of 
farmed or captive cervids, provisions for participating States to administer 
Approved State CWD Herd Certification Programs, and provisions for participating 
herds to become certified as having a low risk of being infected with 
CWD<<< 
 
 Greetings USDA/APHIS et al, 
 
 I kindly would like to comment on Docket No. 00-108-10 Chronic Wasting 
Disease Herd Certification Program and Interstate Movement of Farmed or Captive 
Deer, Elk, and Moose; Program Standards.See attached file(s) 
 
 Attachments (1) 
 
 
 SINGELTARY SUBMISSION ATTACHMENT 
 
 View Attachment: 
 
 Comment from Terry Singeltary This is a Comment on the Animal and Plant 
Health Inspection Service (APHIS) Proposed Rule: Chronic Wasting Disease Herd 
Certification Program and Interstate Movement of Farmed or Captive Deer, Elk, 
and Moose 
 
 
 Singeltary Submissions to Plos and Nature... 
 
 26/01/2016 
 
 *** Alzheimer-type brain pathology may be transmitted by grafts of dura 
mater 26/01/2016 *** 
 
 
 I strenuously once again urge the FDA and its industry constituents, to 
make it MANDATORY that all ruminant feed be banned to all ruminants, and this 
should include all cervids as soon as possible for the following reasons... 
 
 ====== 
 
 In the USA, under the Food and Drug Administrations BSE Feed Regulation 
(21 CFR 589.2000) most material (exceptions include milk, tallow, and gelatin) 
from deer and elk is prohibited for use in feed for ruminant animals. With 
regards to feed for non-ruminant animals, under FDA law, CWD positive deer may 
not be used for any animal feed or feed ingredients. For elk and deer considered 
at high risk for CWD, the FDA recommends that these animals do not enter the 
animal feed system. 
 
 ***However, this recommendation is guidance and not a requirement by law. 
 
 ====== 
 
 31 Jan 2015 at 20:14 GMT 
 
 *** Ruminant feed ban for cervids in the United States? *** 
 
 31 Jan 2015 at 20:14 GMT 
 
 see Singeltary comment ; 
 
 
 *** Singeltary reply ; Molecular, Biochemical and Genetic Characteristics 
of BSE in Canada Singeltary reply ; 
 
 
 26 March 2003 
 
 Terry S. Singeltary, retired (medically) CJD WATCH 
 
 
 The Lancet Infectious Diseases, Volume 3, Issue 8, Page 463, August 2003 
doi:10.1016/S1473-3099(03)00715-1Cite or Link Using DOI 
 
 Tracking spongiform encephalopathies in North America 
 
 Original 
 
 Xavier Bosch 
 
 “My name is Terry S Singeltary Sr, 
 
 
 Diagnosis and Reporting of Creutzfeldt-Jakob Disease 
 
 Singeltary, Sr et al. JAMA.2001; 285: 733-734. Vol. 285 No. 6, February 
14, 2001 JAMA 
 
 Diagnosis and Reporting of Creutzfeldt-Jakob Disease 
 
 Terry S. Singeltary, Sr Bacliff, Tex 
 
 1. Gibbons RV, Holman RC, Belay ED, Schonberger LB. Creutzfeldt-Jakob 
disease in the United States: 1979-1998. JAMA. 2000;284:2322-2323. 
 
 
 2 January 2000 
 
 British Medical Journal 
 
 U.S. Scientist should be concerned with a CJD epidemic in the U.S., as 
well 
 
 
 Tuesday, May 10, 2016 
 
 2015 PDA Virus & TSE Safety Forum Meeting Report 
 
 >>>Recently transmission of prions from blood of patients with 
sporadic CJD to humanized mice could be demonstrated.<<< 
 
 >>>Further-on, urine samples of a control population (normal and 
neurological population) showed no signal in the study; *** however, in samples 
from patients with sporadic CJD and vCJD, a signal was detected in both patient 
populations.<<< 
 
 Meeting Report: 2015 PDA Virus & TSE Safety Forum 
 
 
 Sunday, May 1, 2016 
 
 Center for Biologics Evaluation and Research 25th Meeting of: The 
Transmissible Spongiform Encephalopathies Advisory Committee June 1, 2015 
Transcript 
 
 FOOD AND DRUG ADMINISTRATION 
 
 
 Saturday, April 23, 2016 
 
 v-CJD prion distribution in the tissues of patients at preclinical and 
clinical stage of the disease 
 
 
 Terry S. Singeltary Sr.